STREAMING NOW: Watch Now

Opioid addiction drugs severely underutilized, study finds

A study finds that despite the abili...

Posted: Jun 19, 2018 6:52 AM
Updated: Jun 19, 2018 6:52 AM

A study finds that despite the ability of medication-assisted treatment drugs like methadone and buprenorphine to save the lives of people who've overdosed on opioids, they continue to be underutilized.

The study, published Monday in the medical journal Annals of Internal Medicine, identified and tracked nearly 18,000 adults in Massachusetts who had gone to an emergency room because of a non-fatal drug overdose between 2012 and 2014. It found that only about 30% received any sort of Food and Drug Administration-approved medication-assisted treatment for opioid addiction.

Only three out of 10 people get some sort of FDA-approved drug for opioid addiction treatment

Drugs to treat opioid addiction can reduce risk of death by between 40% and 60%

Such treatment is considered the gold standard for opioid addiction and combines behavioral therapy with one of three approved drugs: methadone; buprenorphine, which is sold as Suboxone; and naltrexone, commonly sold as Vivitrol.

"We were shocked by the fact that so few people are getting medication," said Dr. Marc Larochelle, lead author of the study and an internist and researcher at Boston Medical Center's Grayken Center for Addiction.

Reducing risk of death

Larochelle and his colleagues found that when looking at the entire group a year after their overdoses, nearly 5% of the individuals had died, and about 2% of those deaths were due directly to opioids.

Overall, among those who received methadone, the one-year mortality rate dropped to 2.5%, and for those given buprenorphine, it dropped to 3% -- meaning, one year later, those who were treated with methadone or buprenorphine had reduced their risk of death by 60% and 40%, respectively.

There was no significant difference found in those patients who were treated with naltrexone. However, the study also cautioned that the number of patients using naltrexone was much more limited, which could have affected the finding.

Of the patients followed, researchers found that about 17% used buprenorphine, with median use of the drug around four months; 11% used methadone, with a median use of around five months; and just 6% used naltrexone, with a median use of about one month.

Caleb Banta-Green, who studies drug abuse epidemiology at the University of Washington's School of Public Health, said it's an important limitation, but he also noted that the limited use of just one month was still a noteworthy finding.

Dr. Sharon Stancliff agreed. "If you can't start a treatment, that says a lot about its effectiveness," said Stancliff, a practicing clinician in New York and a former adviser to the Harm Reduction Coalition. Neither she nor Banta-Green was involved in the new study.

There have been high dropout rates when it comes to naltrexone, possibly due to the fact that those starting the regimen cannot used any opioids for at least seven to 10 days. In contrast, methadone and buprenorphine can be started much sooner.

The hurdle in getting people to start naltrexone is also well-known. Randomized clinical trials have compared naltrexone to buprenorphine and found they were similarly effective in keeping people off opioids. But getting patients to start naltrexone has been difficult in these studies, as well.

Limited options when it comes to treatment

The latest study is the first side-by-side comparison in the United States of the impact these three drugs may have on mortality and accounts for how people actually use them.

"People chose to take these drugs out in the real world. And then this is what happened," Banta-Green said, calling it the real world apples-to-apples comparison that many clinicians have been hoping for.

Stancliff said, "this is a study that should be driving policy."

In recent years, Vivitrol, the long-acting injectable version of naltrexone, has become a popular treatment option in the criminal justice system -- and sometimes the only option.

"There's clearly no evidence it should be a preferred treatment, because it is clearly being pushed in some settings where people aren't being offered any other options," Larochelle said.

Fewer than half of all treatment programs prescribe one of the three FDA-approved medications, and only 3% provide all three. The FDA has taken additional steps to make these treatments more accessible. Most notably, in recent months, FDA Commissioner Dr. Scott Gottlieb has prioritized the development of new medication-assisted treatment option.

In the United States, the number of fatal opioid overdoses has continued to rise over the past two decades, and the most recent estimates have nearly 50,000 opioid-related overdoses in 2017. Opioid overdoses kill more people than breast cancer every year.

Larochelle and his colleagues also found that despite having had an overdose, 34% of people were prescribed opioids, and another 26% were prescribed benzodiazepines in the year after their overdoses.

What was clear from the study, Larochelle said, is that more people need to be accessing treatment. "We're not doing enough to reach enough people," he said.

Mississippi Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 61125

Reported Deaths: 1711
CountyConfirmedDeaths
Hinds5209106
DeSoto328027
Madison228154
Rankin212428
Harrison209832
Jackson192934
Jones176557
Forrest163153
Washington148032
Lauderdale132388
Lee123230
Neshoba119487
Lamar111512
Oktibbeha105235
Lowndes97332
Warren96426
Scott95317
Bolivar93932
Copiah90924
Panola90711
Sunflower90622
Lafayette8699
Holmes84347
Leflore83259
Pike82632
Grenada81220
Yazoo77311
Leake76725
Lincoln74339
Wayne73221
Pontotoc7247
Simpson71126
Monroe69750
Coahoma65910
Tate64523
Marion59918
Adams58025
Covington57811
Winston57115
Marshall5668
George5415
Union51913
Newton51611
Attala49524
Tallahatchie49310
Pearl River48236
Walthall44218
Chickasaw43519
Noxubee41710
Claiborne40013
Smith37713
Jasper3758
Calhoun3748
Clay36814
Alcorn3544
Prentiss3376
Hancock32614
Tishomingo3163
Yalobusha31610
Lawrence3135
Itawamba30710
Tippah30412
Clarke29825
Montgomery2913
Humphreys26911
Tunica2656
Carroll24511
Greene22611
Kemper22315
Perry2217
Quitman2211
Amite2105
Jefferson Davis1986
Webster19712
Jefferson1916
Wilkinson18712
Sharkey1801
Stone1483
Choctaw1264
Benton1240
Franklin1142
Issaquena211
Unassigned00

Alabama Coronavirus Cases

Confirmed Cases: 89927

Reported Deaths: 1580
CountyConfirmedDeaths
Jefferson11650225
Mobile8998191
Montgomery6198143
Madison493225
Tuscaloosa391263
Baldwin317522
Shelby300232
Marshall294730
Unassigned263351
Lee249140
Morgan220615
Etowah191425
DeKalb167713
Elmore158437
Calhoun15359
Walker145763
Houston130912
Dallas128023
Russell12201
Franklin118420
Limestone118313
St. Clair118212
Cullman111311
Colbert107612
Lauderdale105312
Autauga101020
Escambia96515
Talladega89013
Jackson8163
Chambers81438
Tallapoosa80478
Dale77619
Butler75135
Blount7223
Covington70420
Coffee7035
Chilton6976
Pike6547
Barbour5625
Lowndes54624
Marion53524
Marengo51514
Clarke4849
Hale44925
Bullock43711
Perry4284
Winston42811
Wilcox4029
Monroe3884
Randolph38810
Conecuh37110
Bibb3643
Pickens3639
Sumter36118
Washington31011
Macon30813
Lawrence3060
Crenshaw2843
Choctaw27312
Henry2433
Greene24011
Cherokee2337
Geneva2260
Clay2165
Lamar1942
Fayette1695
Cleburne1141
Coosa902
Out of AL00
Tupelo
Clear
89° wxIcon
Hi: 91° Lo: 70°
Feels Like: 91°
Columbus
Few Clouds
86° wxIcon
Hi: 90° Lo: 68°
Feels Like: 91°
Oxford
Clear
75° wxIcon
Hi: 87° Lo: 65°
Feels Like: 75°
Starkville
Clear
86° wxIcon
Hi: 90° Lo: 66°
Feels Like: 88°
WTVA Radar
WTVA Temperatures
WTVA Severe Weather